MyFinsight
Home
About
Contact
atyr: the balance sheet
Income Statement
|
Cash Flow
|
Balance Sheet
For the quarter ending 2025-09-30, ATYR has $106,652K in assets.
Balance Sheets Overview
00
No enough data to generate the overview
Buy me a coffee
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS)
Quarterly
123
Balance Sheets
2025-09-30
2025-06-30
Total assets
106,652
101,534
Total liabilities and stockholders equity
106,652
101,534
Unit: Thousand (K) dollars (except for numbers of shares and EPS)
Page 1
Buy me a coffee
Time Plot
Show the time plot by selecting a row from the table.
Balance Sheets
Prepaid expenses
$1,770K
Other receivables
$1,042K
Available-for-sale investments
$84,052K
Cash and cash
equivalents
$6,150K
Other assets
$149K
Financing lease,
right-of-use assets
$745K
Operating lease,
right-of-use assets
$5,603K
Property and equipment,
net
$4,429K
Restricted cash
$2,712K
Total current assets
$93,014K
Total assets
$106,652K
Total liabilities and
stockholders equity
$106,652K
Total stockholders'
equity
$80,044K
Long-term financing lease
liability, net of current...
$398K
Long-term operating lease
liability, net of current...
$10,532K
Total current
liabilities
$15,678K
Noncontrolling interest in
pangu biopharma...
-$191K
Total atyr pharma
stockholders equity
$80,235K
Current portion of
financing lease liability
$630K
Current portion of
operating lease liability
$799K
Accrued expenses
$10,185K
Accounts payable
$4,064K
Accumulated deficit
-$592,201K
Accumulated other
comprehensive loss
-$1K
Additional paid-in capital
$672,339K
Common stock, 0.001 par
value per share...
$98K
Subscribe for Financial Insights
aTYR PHARMA INC (ATYR)
aTYR PHARMA INC (ATYR)